Table of Content

1 Study Coverage
1.1 Vero Cell Rabies Vaccines for Human Product Introduction
1.2 Market by Type
1.2.1 Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Freeze-dried Powder
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vero Cell Rabies Vaccines for Human Sales Estimates and Forecasts 2018-2029
2.2 Global Vero Cell Rabies Vaccines for Human Revenue by Region
2.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2024)
2.2.3 Global Vero Cell Rabies Vaccines for Human Revenue by Region (2024-2029)
2.2.4 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2018-2029)
2.3 Global Vero Cell Rabies Vaccines for Human Sales Estimates and Forecasts 2018-2029
2.4 Global Vero Cell Rabies Vaccines for Human Sales by Region
2.4.1 Global Vero Cell Rabies Vaccines for Human Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024)
2.4.3 Global Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029)
2.4.4 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vero Cell Rabies Vaccines for Human Sales by Manufacturers
3.1.1 Global Vero Cell Rabies Vaccines for Human Sales by Manufacturers (2018-2024)
3.1.2 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vero Cell Rabies Vaccines for Human in 2022
3.2 Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturers
3.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturers (2018-2024)
3.2.2 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vero Cell Rabies Vaccines for Human Revenue in 2022
3.3 Global Key Players of Vero Cell Rabies Vaccines for Human, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Vero Cell Rabies Vaccines for Human Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Product Offered and Application
3.8 Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vero Cell Rabies Vaccines for Human Sales by Type
4.1.1 Global Vero Cell Rabies Vaccines for Human Historical Sales by Type (2018-2024)
4.1.2 Global Vero Cell Rabies Vaccines for Human Forecasted Sales by Type (2024-2029)
4.1.3 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
4.2 Global Vero Cell Rabies Vaccines for Human Revenue by Type
4.2.1 Global Vero Cell Rabies Vaccines for Human Historical Revenue by Type (2018-2024)
4.2.2 Global Vero Cell Rabies Vaccines for Human Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
4.3 Global Vero Cell Rabies Vaccines for Human Price by Type
4.3.1 Global Vero Cell Rabies Vaccines for Human Price by Type (2018-2024)
4.3.2 Global Vero Cell Rabies Vaccines for Human Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vero Cell Rabies Vaccines for Human Sales by Application
5.1.1 Global Vero Cell Rabies Vaccines for Human Historical Sales by Application (2018-2024)
5.1.2 Global Vero Cell Rabies Vaccines for Human Forecasted Sales by Application (2024-2029)
5.1.3 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
5.2 Global Vero Cell Rabies Vaccines for Human Revenue by Application
5.2.1 Global Vero Cell Rabies Vaccines for Human Historical Revenue by Application (2018-2024)
5.2.2 Global Vero Cell Rabies Vaccines for Human Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
5.3 Global Vero Cell Rabies Vaccines for Human Price by Application
5.3.1 Global Vero Cell Rabies Vaccines for Human Price by Application (2018-2024)
5.3.2 Global Vero Cell Rabies Vaccines for Human Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vero Cell Rabies Vaccines for Human Market Size by Type
6.1.1 US & Canada Vero Cell Rabies Vaccines for Human Sales by Type (2018-2029)
6.1.2 US & Canada Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2029)
6.2 US & Canada Vero Cell Rabies Vaccines for Human Market Size by Application
6.2.1 US & Canada Vero Cell Rabies Vaccines for Human Sales by Application (2018-2029)
6.2.2 US & Canada Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2029)
6.3 US & Canada Vero Cell Rabies Vaccines for Human Market Size by Country
6.3.1 US & Canada Vero Cell Rabies Vaccines for Human Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vero Cell Rabies Vaccines for Human Sales by Country (2018-2029)
6.3.3 US & Canada Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vero Cell Rabies Vaccines for Human Market Size by Type
7.1.1 Europe Vero Cell Rabies Vaccines for Human Sales by Type (2018-2029)
7.1.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2029)
7.2 Europe Vero Cell Rabies Vaccines for Human Market Size by Application
7.2.1 Europe Vero Cell Rabies Vaccines for Human Sales by Application (2018-2029)
7.2.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2029)
7.3 Europe Vero Cell Rabies Vaccines for Human Market Size by Country
7.3.1 Europe Vero Cell Rabies Vaccines for Human Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2029)
7.3.3 Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vero Cell Rabies Vaccines for Human Market Size
8.1.1 China Vero Cell Rabies Vaccines for Human Sales (2018-2029)
8.1.2 China Vero Cell Rabies Vaccines for Human Revenue (2018-2029)
8.2 China Vero Cell Rabies Vaccines for Human Market Size by Application
8.2.1 China Vero Cell Rabies Vaccines for Human Sales by Application (2018-2029)
8.2.2 China Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vero Cell Rabies Vaccines for Human Market Size by Type
9.1.1 Asia Vero Cell Rabies Vaccines for Human Sales by Type (2018-2029)
9.1.2 Asia Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2029)
9.2 Asia Vero Cell Rabies Vaccines for Human Market Size by Application
9.2.1 Asia Vero Cell Rabies Vaccines for Human Sales by Application (2018-2029)
9.2.2 Asia Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2029)
9.3 Asia Vero Cell Rabies Vaccines for Human Sales by Region
9.3.1 Asia Vero Cell Rabies Vaccines for Human Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2029)
9.3.3 Asia Vero Cell Rabies Vaccines for Human Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Market Size by Type
10.1.1 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Market Size by Application
10.2.1 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Country
10.3.1 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bharat Biotech Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Company Information
11.2.2 Sanofi-Pasteur Overview
11.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi-Pasteur Recent Developments
11.3 Chengda Bio
11.3.1 Chengda Bio Company Information
11.3.2 Chengda Bio Overview
11.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Chengda Bio Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengda Bio Recent Developments
11.4 Prcmise
11.4.1 Prcmise Company Information
11.4.2 Prcmise Overview
11.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Prcmise Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Prcmise Recent Developments
11.5 Zhuoyi Biological
11.5.1 Zhuoyi Biological Company Information
11.5.2 Zhuoyi Biological Overview
11.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhuoyi Biological Recent Developments
11.6 Ningbo Rongan Biological
11.6.1 Ningbo Rongan Biological Company Information
11.6.2 Ningbo Rongan Biological Overview
11.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ningbo Rongan Biological Recent Developments
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Information
11.7.2 Indian Immunologicals Overview
11.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vero Cell Rabies Vaccines for Human Industry Chain Analysis
12.2 Vero Cell Rabies Vaccines for Human Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vero Cell Rabies Vaccines for Human Production Mode & Process
12.4 Vero Cell Rabies Vaccines for Human Sales and Marketing
12.4.1 Vero Cell Rabies Vaccines for Human Sales Channels
12.4.2 Vero Cell Rabies Vaccines for Human Distributors
12.5 Vero Cell Rabies Vaccines for Human Customers
13 Market Dynamics
13.1 Vero Cell Rabies Vaccines for Human Industry Trends
13.2 Vero Cell Rabies Vaccines for Human Market Drivers
13.3 Vero Cell Rabies Vaccines for Human Market Challenges
13.4 Vero Cell Rabies Vaccines for Human Market Restraints
14 Key Findings in The Global Vero Cell Rabies Vaccines for Human Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Freeze-dried Powder
Table 3. Major Manufacturers of Liquid
Table 4. Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Vero Cell Rabies Vaccines for Human Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Vero Cell Rabies Vaccines for Human Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2018-2024)
Table 9. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2024-2029)
Table 10. Global Vero Cell Rabies Vaccines for Human Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024) & (K Units)
Table 12. Global Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029) & (K Units)
Table 13. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2018-2024)
Table 14. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2024-2029)
Table 15. Global Vero Cell Rabies Vaccines for Human Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Vero Cell Rabies Vaccines for Human Sales Share by Manufacturers (2018-2024)
Table 17. Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Vero Cell Rabies Vaccines for Human Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Vero Cell Rabies Vaccines for Human, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Vero Cell Rabies Vaccines for Human Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Vero Cell Rabies Vaccines for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vero Cell Rabies Vaccines for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vero Cell Rabies Vaccines for Human as of 2022)
Table 23. Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Product Offered and Application
Table 25. Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 28. Global Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 29. Global Vero Cell Rabies Vaccines for Human Sales Share by Type (2018-2024)
Table 30. Global Vero Cell Rabies Vaccines for Human Sales Share by Type (2024-2029)
Table 31. Global Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Vero Cell Rabies Vaccines for Human Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Vero Cell Rabies Vaccines for Human Revenue Share by Type (2018-2024)
Table 34. Global Vero Cell Rabies Vaccines for Human Revenue Share by Type (2024-2029)
Table 35. Vero Cell Rabies Vaccines for Human Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Vero Cell Rabies Vaccines for Human Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 38. Global Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 39. Global Vero Cell Rabies Vaccines for Human Sales Share by Application (2018-2024)
Table 40. Global Vero Cell Rabies Vaccines for Human Sales Share by Application (2024-2029)
Table 41. Global Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Vero Cell Rabies Vaccines for Human Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Vero Cell Rabies Vaccines for Human Revenue Share by Application (2018-2024)
Table 44. Global Vero Cell Rabies Vaccines for Human Revenue Share by Application (2024-2029)
Table 45. Vero Cell Rabies Vaccines for Human Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Vero Cell Rabies Vaccines for Human Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Vero Cell Rabies Vaccines for Human Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Vero Cell Rabies Vaccines for Human Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Vero Cell Rabies Vaccines for Human Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Vero Cell Rabies Vaccines for Human Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 60. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 61. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 62. Europe Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Vero Cell Rabies Vaccines for Human Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 65. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 66. Europe Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Vero Cell Rabies Vaccines for Human Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Vero Cell Rabies Vaccines for Human Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 72. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 73. China Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 74. China Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 75. China Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Vero Cell Rabies Vaccines for Human Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 78. China Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 79. China Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Vero Cell Rabies Vaccines for Human Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 82. Asia Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 83. Asia Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Vero Cell Rabies Vaccines for Human Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 86. Asia Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 87. Asia Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Vero Cell Rabies Vaccines for Human Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Vero Cell Rabies Vaccines for Human Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Vero Cell Rabies Vaccines for Human Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Vero Cell Rabies Vaccines for Human Sales by Region (2018-2024) & (K Units)
Table 93. Asia Vero Cell Rabies Vaccines for Human Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2024-2029) & (K Units)
Table 107. Bharat Biotech Company Information
Table 108. Bharat Biotech Description and Major Businesses
Table 109. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Bharat Biotech Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bharat Biotech Recent Developments
Table 112. Sanofi-Pasteur Company Information
Table 113. Sanofi-Pasteur Description and Major Businesses
Table 114. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sanofi-Pasteur Recent Developments
Table 117. Chengda Bio Company Information
Table 118. Chengda Bio Description and Major Businesses
Table 119. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Chengda Bio Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Chengda Bio Recent Developments
Table 122. Prcmise Company Information
Table 123. Prcmise Description and Major Businesses
Table 124. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Prcmise Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Prcmise Recent Developments
Table 127. Zhuoyi Biological Company Information
Table 128. Zhuoyi Biological Description and Major Businesses
Table 129. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zhuoyi Biological Recent Developments
Table 132. Ningbo Rongan Biological Company Information
Table 133. Ningbo Rongan Biological Description and Major Businesses
Table 134. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ningbo Rongan Biological Recent Developments
Table 137. Indian Immunologicals Company Information
Table 138. Indian Immunologicals Description and Major Businesses
Table 139. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Indian Immunologicals Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Vero Cell Rabies Vaccines for Human Distributors List
Table 145. Vero Cell Rabies Vaccines for Human Customers List
Table 146. Vero Cell Rabies Vaccines for Human Market Trends
Table 147. Vero Cell Rabies Vaccines for Human Market Drivers
Table 148. Vero Cell Rabies Vaccines for Human Market Challenges
Table 149. Vero Cell Rabies Vaccines for Human Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Vero Cell Rabies Vaccines for Human Product Picture
Figure 2. Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vero Cell Rabies Vaccines for Human Market Share by Type in 2022 & 2029
Figure 4. Freeze-dried Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Vero Cell Rabies Vaccines for Human Market Share by Application in 2022 & 2029
Figure 8. Pre-exposure Prophylaxis
Figure 9. Post-exposure Prophylaxis
Figure 10. Vero Cell Rabies Vaccines for Human Report Years Considered
Figure 11. Global Vero Cell Rabies Vaccines for Human Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vero Cell Rabies Vaccines for Human Revenue 2018-2029 (US$ Million)
Figure 13. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2018-2029)
Figure 15. Global Vero Cell Rabies Vaccines for Human Sales 2018-2029 ((K Units)
Figure 16. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Vero Cell Rabies Vaccines for Human Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Vero Cell Rabies Vaccines for Human Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Vero Cell Rabies Vaccines for Human Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Vero Cell Rabies Vaccines for Human Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Vero Cell Rabies Vaccines for Human Sales YoY (2018-2029) & (K Units)
Figure 22. China Vero Cell Rabies Vaccines for Human Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Vero Cell Rabies Vaccines for Human Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Vero Cell Rabies Vaccines for Human Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Vero Cell Rabies Vaccines for Human Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Vero Cell Rabies Vaccines for Human in the World: Market Share by Vero Cell Rabies Vaccines for Human Revenue in 2022
Figure 29. Global Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
Figure 31. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
Figure 32. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
Figure 33. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Vero Cell Rabies Vaccines for Human Revenue Share by Country (2018-2029)
Figure 39. US & Canada Vero Cell Rabies Vaccines for Human Sales Share by Country (2018-2029)
Figure 40. U.S. Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
Figure 43. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
Figure 44. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
Figure 45. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
Figure 46. Europe Vero Cell Rabies Vaccines for Human Revenue Share by Country (2018-2029)
Figure 47. Europe Vero Cell Rabies Vaccines for Human Sales Share by Country (2018-2029)
Figure 48. Germany Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 49. France Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 53. China Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
Figure 54. China Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
Figure 55. China Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
Figure 56. China Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
Figure 57. Asia Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
Figure 58. Asia Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
Figure 59. Asia Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
Figure 60. Asia Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
Figure 61. Asia Vero Cell Rabies Vaccines for Human Revenue Share by Region (2018-2029)
Figure 62. Asia Vero Cell Rabies Vaccines for Human Sales Share by Region (2018-2029)
Figure 63. Japan Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 67. India Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Vero Cell Rabies Vaccines for Human Sales Share by Country (2018-2029)
Figure 74. Brazil Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Vero Cell Rabies Vaccines for Human Revenue (2018-2029) & (US$ Million)
Figure 79. Vero Cell Rabies Vaccines for Human Value Chain
Figure 80. Vero Cell Rabies Vaccines for Human Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed